Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Østergren

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Impotence Research|December 15, 2020
Neglected side effects to curative prostate cancer treatmentsAlexander B Nolsøe, Christian Fuglesang S Jensen, Peter B Østergren, et al.
Scandinavian Journal of Urology|February 22, 2018
Results of 14 years of brachytherapy for localized prostate cancer in Denmark: the Herlev cohortMikael G Jacobsen, Frederik B Thomsen, Mikkel Fode, et al.
BJU International|November 3, 2018
Metabolic consequences of gonadotropin-releasing hormone agonists vs orchiectomy: a randomized clinical studyPeter B Østergren, Caroline Kistorp, Mikkel Fode, et al.
The Journal of Urology|December 13, 2016
Luteinizing Hormone-Releasing Hormone Agonists are Superior to Subcapsular Orchiectomy in Lowering Testosterone Levels of Men with Prostate Cancer: Results from a Randomized Clinical TrialPeter B Østergren, Caroline Kistorp, Mikkel Fode, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Biochemical Recurrence-Free Survival After Radical Prostatectomy in Patients with High-Risk Prostate Cancer: A Nationwide Study of PSMA PET/CT Versus Conventional ImagingAnna W Mogensen, Christian Torp-Pedersen, Mette Nørgaard, et al.
Clinical Genitourinary Cancer|September 8, 2024
Serum Androgens as Predictive Biomarkers: Results From a Randomized Clinical Trial Comparing Enzalutamide and Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate CancerKlara K Ternov, Mikkel Fode, Jens Sønksen, et al.
Archivos Espanoles De Urologia|March 12, 2019
Hormone naïve metastatic prostate cancer: How to treat it?Peter B Østergren, Klara K Ternov, Christian F S Jensen, et al.
The World Journal of Men'S Health|May 14, 2019
The Impact of Testicular Torsion on Testicular FunctionFrederik M Jacobsen, Trine M Rudlang, Mikkel Fode, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Prospective Head-to-Head Comparison of <sup>18</sup>F-PSMA PET/CT and <sup>18</sup>F-NaF PET/CT for Assessing Bone Metastases in 160 Patients with Newly Diagnosed High-Risk Prostate CancerClaus Madsen, Dan Fuglø, Maria Pedersen, et al.
Scandinavian Journal of Urology|January 4, 2019
Male infertility problems of patients with strict sperm morphology between 5-14% may be missed with the current WHO guidelinesChristian Fuglesang S Jensen, Omar Khan, Zainab G Nagras, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Impotence Research|December 15, 2020
Neglected side effects to curative prostate cancer treatmentsAlexander B Nolsøe, Christian Fuglesang S Jensen, Peter B Østergren, et al.
Scandinavian Journal of Urology|February 22, 2018
Results of 14 years of brachytherapy for localized prostate cancer in Denmark: the Herlev cohortMikael G Jacobsen, Frederik B Thomsen, Mikkel Fode, et al.
BJU International|November 3, 2018
Metabolic consequences of gonadotropin-releasing hormone agonists vs orchiectomy: a randomized clinical studyPeter B Østergren, Caroline Kistorp, Mikkel Fode, et al.
The Journal of Urology|December 13, 2016
Luteinizing Hormone-Releasing Hormone Agonists are Superior to Subcapsular Orchiectomy in Lowering Testosterone Levels of Men with Prostate Cancer: Results from a Randomized Clinical TrialPeter B Østergren, Caroline Kistorp, Mikkel Fode, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Biochemical Recurrence-Free Survival After Radical Prostatectomy in Patients with High-Risk Prostate Cancer: A Nationwide Study of PSMA PET/CT Versus Conventional ImagingAnna W Mogensen, Christian Torp-Pedersen, Mette Nørgaard, et al.
Clinical Genitourinary Cancer|September 8, 2024
Serum Androgens as Predictive Biomarkers: Results From a Randomized Clinical Trial Comparing Enzalutamide and Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate CancerKlara K Ternov, Mikkel Fode, Jens Sønksen, et al.
Archivos Espanoles De Urologia|March 12, 2019
Hormone naïve metastatic prostate cancer: How to treat it?Peter B Østergren, Klara K Ternov, Christian F S Jensen, et al.
The World Journal of Men'S Health|May 14, 2019
The Impact of Testicular Torsion on Testicular FunctionFrederik M Jacobsen, Trine M Rudlang, Mikkel Fode, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Prospective Head-to-Head Comparison of <sup>18</sup>F-PSMA PET/CT and <sup>18</sup>F-NaF PET/CT for Assessing Bone Metastases in 160 Patients with Newly Diagnosed High-Risk Prostate CancerClaus Madsen, Dan Fuglø, Maria Pedersen, et al.
Scandinavian Journal of Urology|January 4, 2019
Male infertility problems of patients with strict sperm morphology between 5-14% may be missed with the current WHO guidelinesChristian Fuglesang S Jensen, Omar Khan, Zainab G Nagras, et al.
Pageof 2